相关实验视频
Updated: Sep 17, 2025

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
耐性粉的进步:肥胖管理和低脂肪食品开发的机制,应用和挑战
Yangchao Ou1, Ke Chen2, Jie Guo2
1School of Food Science and Engineering, South China University of Technology, China.
耐药粉 (RS) 通过积极影响肠道微生物群和代谢健康,有利于肥胖管理. 本综述详细介绍了RS类型,机制和功能性食品中的应用,用于肠道健康和体重控制.
科学领域:
- 营养科学 营养科学
- 微生物学 微生物学
- 公共卫生 公共卫生
背景情况:
- 肥胖是一个重大的全球健康挑战,与代谢障碍有关.
- 耐性粉 (RS),一种可发酵的纤维,正在研究其在肥胖管理中的作用.
- 通过RS调节肠道微生物群对于代谢调节至关重要.
研究的目的:
- 审查肥胖症中耐性粉和肠道微生物群之间的关系.
- 阐明RS在代谢调节和肠道健康中的机制.
- 评估功能性食品开发中的RS应用和挑战.
主要方法:
- 对抗性粉 (RS) 和肠道微生物群相互作用的文献综述.
- 分析RS分类 (RS1-RS5) 及其代谢影响.
- 评估RS对微生物组成,SCFA生产和肠道屏障的影响.
主要成果:
- RS发酵会影响肠道微生物群的组成和短链脂肪酸 (SCFA) 的产生.
- RS影响食欲,脂质代谢和炎症,有助于代谢调节.
- 不同的RS类型表现出多样化的效果,具有针对性肥胖干预的潜力.
结论:
- 耐药粉有望通过肠道微生物群调节来控制肥胖.
- 对于RS的精确饮食干预措施,需要使用多omics进行进一步的研究.
- 在功能性食品中优化RS需要解决处理挑战,以提高有效性.
更多相关视频
05:22Transverse Sectioning of Mature Rice Oryza sativa L. Kernels for Scanning Electron Microscopy Imaging Using Pipette Tips as Immobilization Support
Published on: January 25, 2022
10:05Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
Published on: March 20, 2017
相关概念视频
Obesity
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...